Submission Details
| 510(k) Number | K251006 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2025 |
| Decision Date | November 10, 2025 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
K251006 is an FDA 510(k) clearance for the NeVasc Aspiration System, a Catheter, Thrombus Retriever (Class II — Special Controls, product code NRY), submitted by Vesalio, Inc. (San Diego, US). The FDA issued a Cleared decision on November 10, 2025, 223 days after receiving the submission on April 1, 2025. This device falls under the Neurology review panel. Regulated under 21 CFR 870.1250.
| 510(k) Number | K251006 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | April 01, 2025 |
| Decision Date | November 10, 2025 |
| Days to Decision | 223 days |
| Submission Type | Traditional |
| Review Panel | Neurology (NE) |
| Summary | Summary PDF |
| Product Code | NRY — Catheter, Thrombus Retriever |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.1250 |
| Definition | The Device Is Intended To Restore Blood Flow By Removing Thrombus/clots In Patients Experiencing Ischemic Stroke. The Prior Clearances In This Category Have Been Limited To Simply Identifying Catheter Placed In The Peripheral, Coronary, And Neurovasculature. It Is Felt That This Is A Unique Claim And Should Not Be Combined With Previously Cleared Catheters Under A General Procode. |